ORLANDO—For stratifying risk in patients with coronary events, renal dysfunction adds incremental value to the Thrombolysis in Myocardial Infarction (TIMI) score, investigators reported at the 58 th ...
Please provide your email address to receive an email when new articles are posted on . Coronary artery calcification scoring in combination with clinical risk assessment using the TIMI score reliably ...
Background: The Thrombolysis in Myocardial Infarction (TIMI) risk score uses clinical data to predict the short-term risk of acute myocardial infarction, coronary revascularization or death from any ...
Please provide your email address to receive an email when new articles are posted on . Among patients who underwent primary PCI for STEMI, results from a recent study have suggested that the TIMI ...
The MERLIN-TIMI 36 trial shows that the use of ranolazine can be extended to a broader population of patients than previously studied who present with an acute coronary syndrome. Presenter: David A.
This randomized, double-blind, placebo-controlled multinational trial involved 6,560 patients within 48 hours of ischemic symptoms. Ranolazine was initiated intravenously then followed by oral ...
CMAJ June 07, 2010 DOI: https://doi.org/10.1503/cmaj.092119 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results